Manejo Conservador de Retención de Productos de la Concepción con Anticonceptivos Orales Combinados. Presentación de Caso
RETAINED PRODUCTS OF CONCEPTION Conservative Management of Retained Products of Conception with Combined Oral Contraceptives. Case Report
Cómo citar
Descargar cita
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
RESUMEN
Objetivo: presentar el caso de una paciente con retención de productos de la concepción (RPC) después de aborto médico, tratada con anticonceptivos orales combinados (ACOC), y efectuar revisión de la literatura. Caso Clínico: paciente de 37 años, con sangrado genital escaso y leve dolor pélvico, quien tuvo aborto provocado con misoprostol cuatro días antes, acude sin signos de infección, con endometrio mixto de 18,5 mm. Durante seis semanas de seguimiento persiste sangrado y endometrio mixto engrosado, con disminución lenta de la gonadotrofina corionica humana (GCH); se sospecha RPC, se suministra ciclo de ACOC y al terminarlos expulsa completamente el tejido retenido. Metodología: búsqueda bibliográfica en bases de datos Google Scholar, Science Direct, RIMA, PubMed. Revisión de literatura: la RPC se presenta después de parto o aborto (más frecuente). Criterios diagnósticos: sangrado persistente, hallazgos ecográficos y medición de GCH. Diagnóstico diferencial: enfermedad trofoblastica gestacional y malformaciones arteriovenosas uterinas. Es factible el manejo conservador, con bajas tasas de infección o procedimientos quirúrgicos. Ante la evolución prolongada, presencia de signos de infección o hemorragia importante, se impone la evacuación quirúrgica, tradicionalmente con dilatación y legrado, y más recientemente resección histeroscópica. La bibliografía reciente sugiere el uso de ACOC como manejo médico. En nuestro caso, la paciente tomó un ciclo de ACOC y al terminarlos presentó expulsión de los restos retenidos. Conclusiones: el manejo conservador de la RPC con ACOC surge como una opción en casos seleccionados; son necesarios estudios controlados para definir su utilidad.
Palabras clave: misoprostol, aborto incompleto, anticonceptivos orales combinados.
Visitas del artículo 2293 | Visitas PDF 40
Descargas
- Debby A, Malinger E, Harow E, Golan A, Glezerman M. Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception. Ultrasound Obstet Gynecol. 2006; 27(1):61-64. DOI: 10.1002/uog.2654
- , Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception, Int J Gynecol Obstet. 2014; 127(1):86-89. http://dx.doi.org/10.1016/j.ijgo.2014.05.003
- Hooker AB, Aydin H, Brôlmann HA, Huirne JA. Long term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertility and Sterility. 2016; 105(1):156-164. https://doi.org/10.1016/j.fertnstert.2015.09.021
- Klement AH, Frederic M, Bentov Y, Chang P, Nayot D, Haas J, et al. Oral contraceptive pills as an option for non-surgic al management of retained products of conception-a preliminary study. Gynecol Endocrinol. 2018; 34(7):609-611. DOI: 10.1080/09513590.2018.1427714
- Jimenez JS, Gonzalez C, Alvarez C, Muñoz L, Perez C, Muñoz J. Conservative management of retained trophoblastic tissue and placental polyp with diagnostic ambulatory hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2009; 145(1): 89–92. https://doi.org/10.1016/j.ejogrb.2009.04.001
- Harish KM, Shwetha N, Dipankar D. Comparative análisis of hysteroscopy versus suction evacuation in the management of retained products of conception. Int J Reprod Contracept Obstet Gynecol. 2018; 7(6):2155-2159. http://dx.doi.org/10.18203/2320-1770.ijrcog20182009
- Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB, Kamaya A. Physiologic, Histologic, and Imaging Features of Retained Products of Conception. Radiographics. 2013; 33(3):781-796. DOI: 10.1148/rg.333125177
- Casikar I, Bignardi T, Riemke J, Alhamdan D, Condous G. Expectant management of spontaneous first-trimester miscarriage: pospective validation of the “2 weeks rule”. Ultrasound Obstet Gynecol. 2010; 35(2): 223–227. DOI: 10.1002/uog.7486
- Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ. 2006; 332(7552):1235-1240. DOI: 10.1136/bmj.38828.593125.55
- Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of Serum Human Chorionic Gonadotropin and Spontaneous Complete Abortion: defining the Normal Curve. Obstet Gynecol. 2004; 104(5) 975-981. DOI: 10.1097/01.AOG.0000142712.80407.fd
- Pocius KD, Maurer R, Fortin J, Goldberg AB, Bartz D. Early serum human chorionic gonadotropin (hCG) trends after medication abortion. Contraception. 2015; 91(6): 503–506. DOI: 10.1016/j.contraception.2015.03.004
- Pourali L, Ayati S, Layegh P, Vatanchi A, Rastin Z, Shourvi A. Persistent low levels of Beta-hCG: a pitfall in diagnosis of Retained products of Conception. Acta Med Iran. 2018; 56(7):478-481.
- Tohma YA, Dilbaz B, Evliyaoğlu O, Çoşkun B, Çolak E, Dilbaz S. Is ultrasonographic evaluation essential for diagnosis of retained products of conception after surgical abortion? J Obstet Gynaecol Res. 2016; 42(5):489-495. https://doi.org/10.1111/jog.12944
- Reeves MF, Fox MC, Lohr PA, M. D. Creinin MD. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol. 2009; 34(1):104–109. DOI: 10.1002/uog.6404
- Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volumen on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol. 2007; 29(2):205–209. DOI: 10.1002/uog.3914
- Chopra N, Kaur M, Kaur-Mohi M. Correlation of ultrasound with histopathology for retained products of conception in medically managed abortions. Int J Reprod Contracept Obstet Gynecol. 2017; 6(8):3372-3375. http://dx.doi.org/10.18203/2320-1770.ijrcog20173373
- Hameed BH. Incomplete miscarriage, expectant versus medical management and the use of Doppler sonography for patient selection. Iraqi J Comm Med. 2016; 2:10-15.
- Van den Bosch T, Van Schoubroeck D, Timmerman D. Maximum Peak Systolic Velocity and Management of Highly Vascularized Retained Products of Conception. J Ultrasound Med. 2015; 34(9):1577–1582. DOI: 10.7863/ultra.15.14.10050
- Betel C, Atri M, Arenson AM, Khalifa M, Osborne R, Tomlinson G. Sonographic Diagnosis of Gestational Trophoblastic Disease and Comparison With Retained Products of Conception. J Ultrasound Med. 2006; 25(8):985–993. DOI: 10.7863/jum.2006.25.8.985
- Jain K, Fogata M. Retained Products of Conception Mimicking a Large Endometrial AVM: Complete Resolution Following Spontaneous Abortion. J Ultrasound Med. 2007; 35(1):42-47. DOI: 10.1002/jcu.20250
- Vilos AG, Vilos GA, Hollett-Caines J, Rajakumar C, Garvin G, Kozack R. Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes. Hum Reprod. 2015; 30(7):1599–1605. DOI: 10.1093/humrep/dev097
- Hashim H, Nawawi O. Uterine arteriovenous malformation. Malays J Med Sci. 2013; 20(2):76-80.
- Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017; 1:1-2. DOI: 10.1002/14651858.CD007223.pub4
- Lemmers M, Verschoor MA, Regenrink KO, Naaktgeboren C, Opmeer BC, Bossuyt PM, et al. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial. Hum Reprod. 2016; 31(11):2421-2427. DOI:10.1093/humrep/dew221
- Kaviani M, Tehrani TA, Azima S, Abdali K, Asadi N. Comparison of the Effects of Simultaneous Use of Methylergonovine and Combined Low-dose (LD) Contraceptive Pills on Hemorrhage Due to Retained Pregnancy Products after Abortion. Int J Curr Microbiol App Sci. 2016; 5(11):499-507. http://dx.doi.org/10.20546/ijcmas.2016.511.058
- Lethaby A, Wise MR, Weterings MA, Bofill-Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2:1-3. DOI: 10.1002/14651858.CD000154.pub3
- Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception. 1998; 58(2):99-103. DOI: 10.1016/s0010-7824(98)00072-9
- Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014; 173:19–22. https://doi.org/10.1016/j.ejogrb.2013.11.020
Información
